ProfileGDS4718 / 1565737_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 31% 26% 29% 29% 25% 23% 25% 29% 24% 27% 31% 30% 19% 22% 27% 29% 26% 25% 29% 26% 28% 26% 21% 28% 24% 22% 26% 30% 28% 25% 25% 31% 26% 22% 20% 27% 21% 23% 19% 28% 22% 25% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4652328
GSM549102patient 115, normal, homogenized [OPG study]4.5836331
GSM549104patient 119, normal, homogenized [OPG study]4.3670226
GSM549108patient 138, normal, homogenized [OPG study]4.5277629
GSM549119patient 077, normal, homogenized [OPG study]4.5192329
GSM549133patient 032, cancer, homogenized [OPG study]4.2837825
GSM549139patient 042, cancer, homogenized [OPG study]4.2503123
GSM549099patient 107, normal, homogenized [OPG study]4.3518125
GSM549109patient 139, normal, homogenized [OPG study]4.5099529
GSM549110patient 046, normal, homogenized [OPG study]4.3131424
GSM549114patient 063, normal, homogenized [OPG study]4.3587927
GSM549122patient 082, normal, homogenized [OPG study]4.5878631
GSM549134patient 033, cancer, homogenized [OPG study]4.5263530
GSM549136patient 036, cancer, homogenized [OPG study]4.0579819
GSM549140patient 044, cancer, homogenized [OPG study]4.1667722
GSM549111patient 047, normal, homogenized [OPG study]4.4067827
GSM549113patient 057, normal, homogenized [OPG study]4.4522229
GSM549132patient 031, cancer, homogenized [OPG study]4.3648826
GSM549137patient 038, cancer, homogenized [OPG study]4.3168325
GSM549142patient 047, cancer, homogenized [OPG study]4.612729
GSM549100patient 110, normal, homogenized [OPG study]4.3766826
GSM549107patient 135, normal, homogenized [OPG study]4.4123828
GSM549115patient 068, normal, homogenized [OPG study]4.3126426
GSM549116patient 072, normal, homogenized [OPG study]4.1778121
GSM549120patient 078, normal, homogenized [OPG study]4.4560728
GSM549131patient 030, cancer, homogenized [OPG study]4.2362724
GSM549118patient 074, normal, homogenized [OPG study]4.2111722
GSM549129patient 027, cancer, homogenized [OPG study]4.390826
GSM549123patient 088, normal, homogenized [OPG study]4.5146830
GSM549124patient 006, cancer, homogenized [OPG study]4.5042428
GSM549126patient 015, cancer, homogenized [OPG study]4.3437925
GSM549128patient 025, cancer, homogenized [OPG study]4.3176825
GSM549103patient 117, normal, homogenized [OPG study]4.6361831
GSM549117patient 073, normal, homogenized [OPG study]4.3590426
GSM549138patient 041, cancer, homogenized [OPG study]4.1934122
GSM549141patient 045, cancer, homogenized [OPG study]4.070420
GSM549130patient 028, cancer, homogenized [OPG study]4.423427
GSM549101patient 111, normal, homogenized [OPG study]4.2107921
GSM549105patient 128, normal, homogenized [OPG study]4.2601423
GSM549106patient 134, normal, homogenized [OPG study]4.0682419
GSM549112patient 048, normal, homogenized [OPG study]4.4324228
GSM549125patient 011, cancer, homogenized [OPG study]4.2361522
GSM549127patient 024, cancer, homogenized [OPG study]4.3246325
GSM549135patient 035, cancer, homogenized [OPG study]4.466429